Thus, if one populace dies younger than another due to genetic distinctions, a non-remediable/controllable factor, we have a tendency to state that there is a health and wellness inequality. On the other hand, if a population has a reduced life expectancy because of lack of accessibility to drugs, the situation would be identified as a health and wellness injustice. These inequities might include distinctions in the "presence of condition, health results, or accessibility to health care" in between populaces with a different race, ethnic culture, sexual preference or socioeconomic status.